# persona_off · bixbench · bix-3-q5

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original**; attempt: **1**.
- Native status: **scored**; normalized native score: **100/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect the supplied workbook and any repository documentation only; do not run the full differential-expression analysis yet. Report the worksheet layout, gene identifiers, sample counts and tissue labels, normalized-count properties, and how samples link to mapping metadata. Determine whether subject pairing, response groups, or other required adjustments are documented, without inferring undocumented code meanings. Propose a feasible differential-expression approach for the three requested contrasts and explain precisely how the binomial exact test at a 5% threshold would be applied (trials, successes, null probability, alternative, and any multiplicity adjustment). Flag ambiguity in the meaning of 'negligible effects' and distinguish assumptions from source-supported choices. Include any consequential limitations of the available count data and a proposed path for the executed analysis script or notebook.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The provided context identifies Mapping_statistics and NormCount worksheets, with baseline blood, dentate gyrus, and final blood blocks and potential sample metadata. Data structure, pairing, preprocessing, and the intended binomial-test definition still require inspection.
````

**Objectives Open**

````text
[
  "Inspect input structure and metadata and identify consequential uncertainties.",
  "Agree on differential-expression and exact-binomial testing methods for all three comparisons.",
  "Execute the agreed analysis, retain an analysis artifact, and identify the comparison showing negligible effects."
]
````

### Event 10 — Actor

**Answer**

````text
Inspection only is complete; no differential-expression or binomial tests have been run. Approval is requested before implementation.

SOURCE-SUPPORTED FINDINGS
• The repository contains only task.json and the supplied workbook; no methods README or analysis code. The workbook has two visible sheets, no comment files or defined names.
• Mapping_statistics: 91 rows × 22 columns (header plus 90 samples). The substantive columns are Index, Sample ID, total read, NH:i:1, HI:I:0, mapping rate, Response, Tissue, Code, DESeq (count-file name), and Index_DESeq. Columns 12–16 contain quoting/code/group fragments rather than additional biological covariates; columns 17–22 are empty below their headers.
• NormCount: 25,406 rows × 188 columns. Rows 1–3 provide grouped headings; row 4 is the column header; rows 5–25,406 contain 25,402 genes. Columns 1–2 are Index and GeneID; 3–32 baseline blood, 33–62 dentate gyrus, 63–92 final blood. Columns 93–98 contain tissue maxima/medians. Columns 99–179 contain nine precomputed blocks headed 'DESeq, Comparison [1–9], exclude outliers', with base means, fold changes, pval, padj, and DEG flags; columns 180–188 repeat comparison DEG summaries. No contrast definitions or outlier criteria are documented, so I would not assign these numbered comparisons to the requested contrasts.
• GeneID has 25,402 unique, nonmissing symbol-like identifiers (e.g., 0610007C21Rik, Zyx, Zzz3), not Ensembl IDs. Organism/annotation version is not explicitly documented; symbol appearance alone is not sufficient provenance.
• Tissue labels in metadata are baseline_blood, dentate_gyrus, final_blood. Each has 30 samples: 10 Control, 10 good_responder, 10 bad_responder. Response-group names are explicit, but criteria defining response are absent.
• All 90 expression headers match the 90 unique Mapping_statistics.Code values exactly, with no unmatched samples. This is the join key; use metadata Tissue and Response, not decoded filename suffixes. For example, Sample ID um_mueller_2017_02_23_102_bl is explicitly labelled bad_responder_dentate_gyrus2 despite its suffix.
• The 25,402 × 90 normalized-count matrix contains 2,286,180 finite nonnegative values, no missing values, 700,666 zeros, and 1,571,838 noninteger values. Range: 0–57,771,177.4. There are 2,210 all-zero genes (also the only genes constant over all 90 samples). Sample column sums range from 10,952,979.24 to 78,311,142.37. Mapping rates range from 60.94% to 94.68%.

PAIRING AND ADJUSTMENTS
There is no explicit subject-ID column, pairing dictionary, batch variable, sex/age covariate, or required model formula. Repeated numeric tokens and matching within-response sample ordinals across tissues suggest possible pairing, but their meanings are undocumented. I will not treat these as verified subjects or decode c/g/b/bl/fi into biological meanings. Response is documented and can be included as a categorical adjustment; doing so is a proposed modeling choice, not a documented original method. Subject independence would be a consequential working assumption, not an established fact. The outlier-exclusion wording on the existing DESeq results is documented, but neither exclusion identities nor rules are available.

PROPOSED ANALYSIS, SUBJECT TO APPROVAL
1. Create analysis/tissue_differential_expression.py, with input checks, sample metadata joins, saved gene-level results, and contrast/binomial summary tables. No claim of an executed analysis artifact is made at this stage.
2. Use only the 90 normalized expression columns, not the undocumented comparison blocks. Remove the 2,210 globally all-zero genes; retain other genes with estimable positive residual variance for each contrast, recording exact denominators and exclusions. Do not invent low-expression or outlier thresholds.
3. For each requested pair (Final minus Baseline Blood; Dentate gyrus minus Baseline Blood; Dentate gyrus minus Final Blood), fit a gene-wise linear model to log2(normalized count + 1), using tissue plus categorical Response. Use heteroskedasticity-robust HC3 coefficient tests with residual-degrees-of-freedom t calibration. This is a feasible approximate analysis of continuous normalized data, not a reconstruction of the workbook's DESeq analysis. Report coefficients and both nominal p-values and Benjamini–Hochberg q-values within each contrast. A tissue-by-response model/equal-response-average contrast can serve as a sensitivity check if response heterogeneity matters. Pairing will not be introduced absent explicit approval of a clearly labelled assumption.
4. Precisely specified proposed binomial interpretation: for each contrast, each tested gene is one trial (n); a success is a nominal, two-sided gene-level p-value <0.05 (k); under the global null the success probability is p0=0.05. Compute scipy.stats.binomtest(k,n,p=0.05,alternative='greater') to test enrichment of nominal differential signals. Report k, n, k/n, and exact-test p-values. Apply Holm correction across the three binomial p-values, judging evidence of enrichment at adjusted p<0.05; retain unadjusted values for transparency. Do not count BH-significant genes as Bernoulli(0.05) successes, because that would not have this null probability. BH DEG counts are supplementary, separate summaries.

INTERPRETATION AND LIMITATIONS
The task specifies a binomial exact test and a 5% threshold, but not the trial definition, null probability, direction, or multiplicity convention. The above is an explicit proposal, not a sourced original protocol. 'Negligible effects' could mean no excess nominal discoveries, few FDR discoveries, small expression changes, or formal biological equivalence. Under the proposal, lack of enrichment means only insufficient evidence of excess differential signal; it does not prove negligible effect sizes. I would compare discovery fractions and effect-size distributions, and avoid an equivalence claim without a prespecified biological margin.

The binomial calculation is exact only under independent Bernoulli trials with the specified probability. Correlated genes and approximate gene-level p-values violate that idealization; its p-value must be labelled a heuristic global summary. Samples may also be repeated measurements, making unpaired-model inference uncertain. Normalized fractional values cannot legitimately be rounded and passed off as original DESeq/negative-binomial counts; raw counts, size factors, normalization details, and dispersion/outlier settings are absent. Read totals do not reconstruct raw gene counts. Very large counts, substantial sparsity, and tissue composition differences warrant diagnostics. No tissue comparison can yet be selected as the answer from inspection alone.
````

**Stage**

````text
plan
````

**Evidence**

````text
Observed 90/90 unique Code-header matches; tissue × Response table has nine cells of 10 samples each. NormCount has 25,402 unique genes and 2,210 all-zero rows, leaving at most 23,192 genes before contrast-specific estimability exclusions. Workbook includes nine numbered DESeq result blocks without contrast definitions, and no explicit subject or batch column. Inspection executed via openpyxl/NumPy only; no inferential analyses were run.
````

**Assumptions**

````text
[
  "Proposed log2(count+1) analysis treats available values as normalized continuous expression, not raw counts.",
  "Primary unpaired modeling would assume independent samples because subject identity is unverified.",
  "Response adjustment, nominal-gene-p-value binomial successes, one-sided enrichment, and Holm correction are proposed choices requiring approval."
]
````

**Uncertainties**

````text
[
  "Subject pairing and biological meanings of filename tokens are not documented.",
  "Normalization algorithm, raw counts, original outlier exclusions and numbered DESeq contrast definitions are unavailable.",
  "'Negligible effects' and the intended binomial trial/null construction are not defined by supplied documentation."
]
````

### Event 11 — Simulator

**Message**

````text
Approved: execute the proposed response-adjusted log2(normalized count + 1) HC3 analysis for all three contrasts, with nominal p<0.05 successes in the one-sided exact binomial enrichment test against p0=0.05, and report both raw and Holm-adjusted binomial p-values. These are explicit working choices, not recovered source methods. Keep BH discovery counts separate. Do not infer pairing or assign the undocumented DESeq blocks to contrasts. Include the proposed tissue-by-response sensitivity analysis to assess whether averaging responses masks heterogeneous effects. Record tested-gene denominators, variance/estimability exclusions, discovery counts and fractions, and effect-size summaries alongside basic model diagnostics. Interpret lack of enrichment as lack of evidence, not equivalence; if all contrasts show enrichment, assess relative effect magnitude without calling a nonsignificant global test that did not occur. Provide the concise best-supported answer to which comparison shows negligible effects, noting consequential uncertainty if needed, and retain the executed script at analysis/tissue_differential_expression.py (or report its actual path). Final submission must include stage='final', answer, payload.executed_analysis=true only after execution, and artifacts.analysis pointing to the executed script or notebook.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
Inspection reports a complete 90-sample metadata join, balanced tissue-by-response groups, normalized fractional expression and 23,192 non-all-zero genes. Raw counts, pairing, original contrast definitions and binomial specifications are unavailable. The proposed method is executable and transparently distinguishes assumptions from documented input properties.
````

**Objectives Open**

````text
[
  "Execute the three differential-expression contrasts and exact binomial tests with reported diagnostics.",
  "Evaluate response heterogeneity and identify the comparison with negligible relative effects without claiming formal equivalence.",
  "Return the concise answer and executed analysis artifact under the submission contract."
]
````

### Event 18 — Actor

**Answer**

````text
Final vs Baseline Blood shows the smallest expression effects relative to either dentate-gyrus comparison. However, none of the three comparisons shows negligible effects in the sense of lacking binomial enrichment: all are strongly enriched for differential-expression signals. Thus, Final vs Baseline Blood is the best-supported relative answer, not evidence of biological equivalence.
````

**Stage**

````text
result
````

**Evidence**

````text
Execution completed successfully (exit 0), including a rerun using stable log-summed binomial tails to resolve floating-point underflow. Six gene-level CSV files, summary.json, and execution.log were produced by the retained script.

PRIMARY RESPONSE-ADJUSTED HC3 RESULTS
Contrast | Tested genes | Additional exclusions after 2,210 global all-zero genes | Nominal p<0.05 successes | BH q<0.05 discoveries | Median absolute log2(count+1) effect | Fraction absolute effect >1
Final–Baseline Blood | 22,060 | 1,132 | 11,083 (50.24%) | 9,989 (45.28%) | 0.217 | 3.91%
Dentate–Baseline Blood | 23,017 | 175 | 19,526 (84.83%) | 19,403 (84.30%) | 1.179 | 54.81%
Dentate–Final Blood | 22,890 | 302 | 19,305 (84.34%) | 19,165 (83.73%) | 1.208 | 55.38%

Additional exclusions were genes with residual sum of squares or HC3 contrast variance <=1e-20, or nonfinite variance. Every pair contains 60 samples, balanced across tissue and response groups. BH correction was performed separately within each contrast and never used to define binomial successes.

BINOMIAL EXACT TEST
Trials = tested genes; successes = two-sided HC3 nominal p<0.05; null probability = 0.05; alternative = greater. Holm adjustment covers the three primary contrast tests. Raw and Holm-adjusted log10(p), respectively:
• Final–Baseline: −8025.479, −8025.479.
• Dentate–Baseline: −21229.487, −21229.010.
• Dentate–Final: −20883.787, −20883.486.
Ordinary floating-point exact-test p-values underflow to zero; these log-scale tail sums represent extremely small positive probabilities, not literal zero. All reject enrichment nulls at 5%, before and after Holm adjustment. No nonsignificant global test occurred.

EFFECT-SIZE DISTRIBUTIONS
Absolute-effect quartiles (25th, 50th, 75th percentiles) are 0.086/0.217/0.431 for Final–Baseline, 0.395/1.179/2.865 for Dentate–Baseline, and 0.401/1.208/2.973 for Dentate–Final. Their 95th percentiles are 0.935, 7.361, and 7.509. These are differences of mean log2(count+1), not exact raw-count log fold changes.

TISSUE-BY-RESPONSE SENSITIVITY
The interaction model estimates an equally weighted average of the three response-specific tissue effects. Balanced sampling makes those average estimates identical to the additive estimates, but standard errors differ. Tested denominators/exclusions are unchanged. Nominal discoveries are 10,966 (49.71%), 19,483 (84.65%), and 19,253 (84.11%); BH discoveries are 9,830 (44.56%), 19,380 (84.20%), and 19,129 (83.57%), respectively. Raw/Holm log10 binomial p-values are −7875.915/−7875.915, −21142.488/−21142.011, and −20779.466/−20779.165 (Holm applied separately to sensitivity tests).
For Final–Baseline, response-specific median absolute effects are 0.202 Control, 0.302 good_responder, and 0.298 bad_responder. Response-specific tested/nominal/BH counts are 20,956/6,014/3,831; 20,783/7,962/6,208; and 20,879/9,155/7,751. Thus averaging does not conceal an otherwise absent blood effect; responder effects are somewhat larger. Dentate comparison response-specific medians remain 1.228–1.300. Across the 23,192 globally nonzero genes, 30.43% have mixed response-specific effect signs in the blood contrast (often small effects), versus 7.79% and 8.57% in dentate contrasts. Only 0.418% have blood average absolute effect <0.25 while some group has absolute effect >1, versus 0% and 0.0345% for dentate contrasts. These descriptive thresholds assess cancellation, not a prespecified equivalence margin or a formal interaction test.

BASIC MODEL DIAGNOSTICS
All primary designs have rank 4/4, residual df=56, condition number 4.22, and uniform leverage 0.0667. Interaction designs have rank 6/6, df=54, condition number 9.77, and leverage 0.10. Median residual variances on the transformed scale are 0.124, 0.120, and 0.141 for primary models; no rank deficiency was found. Full quantiles and group-specific sensitivity results are retained in summary.json. No inferred pairing, undocumented DESeq contrast assignment, or invented outlier exclusions were used.
````

**Assumptions**

````text
[
  "Normalized expression was modeled as log2(count+1) with categorical Response adjustment and HC3 standard errors, using residual-df t calibration; these are approved working methods, not recovered original methods.",
  "Samples were treated as independent because subject pairing is undocumented.",
  "Binomial calculations assume independent, correctly calibrated gene-level null trials; actual gene dependence means the exact binomial tail is only a heuristic global summary."
]
````

**Uncertainties**

````text
[
  "Raw gene counts, normalization/size-factor provenance, and original DESeq outlier rules are absent; the analysis is approximate and does not reconstruct DESeq.",
  "Potential repeated measurements could change inference, but subject identities were not inferred from codes.",
  "No biological equivalence margin defines 'negligible'; the blood comparison has smaller effects but substantial differential expression, so an unqualified no-effect claim would contradict the executed results."
]
````

### Event 19 — Simulator

**Message**

````text
The reported analysis adequately addresses the agreed approach. Submit the final candidate identifying Final vs Baseline Blood as showing the smallest relative effects, while retaining the qualification that all three contrasts show significant binomial enrichment and therefore none supports an unqualified absence-of-effect conclusion. Include stage='final', the concise answer, payload.executed_analysis=true, and artifacts.analysis='analysis/tissue_differential_expression.py'.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
Reported execution includes all three contrasts, response-adjusted HC3 tests, exact binomial tails with Holm correction, separate BH counts, interaction sensitivity analysis, and estimability diagnostics. The blood contrast has median absolute transformed effect 0.217 versus 1.179 and 1.208 for dentate contrasts, but 50.24% nominal discoveries and strong binomial enrichment. The candidate preserves this distinction and supplies the required execution artifact; no identifiable mismatch warrants revision.
````

**Objectives Open**

````text
[]
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/bixbench_bix-3-q5-0103ba515ae2/persona_off/attempt-1/output/bixbench_bix-3-q5-0103ba515ae2/controller/events.jsonl",
  "event_log_sha256": "84c49f32f3dc6bc98ac0cc5881c9630dd5dbe6b2748d254e8405670df0716c51",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
